Macular Degeneration Treatment Market Size, Share, And Growth Report 2032
Macular Degeneration Treatment Market by Drug Class (Anti-VEGFs and Other Drugs), by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)), by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 10.02 Billion | USD 20.54 Billion | 8.3% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Macular Degeneration Treatment Market, 2016 - 2025, (USD Million)
- 2.2. Macular Degeneration Treatment Market: Snapshot
- Chapter 3. Global Macular Degeneration Treatment Market - Industry Analysis
- 3.1. Macular Degeneration Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Macular Degeneration
- 3.2.2. Increasing Geriatric Population
- 3.3. Restraints
- 3.3.1. Off-label Use of Drugs
- 3.4. Opportunity
- 3.4.1. Emerging Markets
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by drug class segment
- 3.6.2. Market attractiveness analysis by indication segment
- 3.6.3. Market attractiveness analysis by distribution channel segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Macular Degeneration Treatment Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global macular degeneration treatment market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New drug class launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Macular Degeneration Treatment Market - Drug Class Segment Analysis
- 5.1. Global macular degeneration treatment market overview: by drug class
- 5.1.1. Global macular degeneration treatment market revenue share, by drug class, 2018 and 2025
- 5.2. Anti-vascular Endothelial Growth Factor (VEGFs)
- 5.2.1. Global macular degeneration treatment market by Anti-vascular Endothelial Growth Factor (VEGFs), 2016-2025 (USD Million)
- 5.3. Other Drugs
- 5.3.1. Global macular degeneration treatment market by Other Drugs, 2016-2025 (USD Million)
- 5.1. Global macular degeneration treatment market overview: by drug class
- Chapter 6. Global Macular Degeneration Treatment Market - Indication Segment Analysis
- 6.1. Global macular degeneration treatment market overview: by indication
- 6.1.1. Global macular degeneration treatment market revenue share, by indication, 2018 and 2025
- 6.2. Wet Age-related Macular Degeneration (wAMD)
- 6.2.1. Global macular degeneration treatment market by Wet Age-related Macular Degeneration (wAMD), 2016-2025 (USD Million)
- 6.3. Dry Age-related Macular Degeneration (dAMD)
- 6.3.1. Global macular degeneration treatment market by Dry Age-related Macular Degeneration (dAMD), 2016-2025 (USD Million)
- 6.1. Global macular degeneration treatment market overview: by indication
- Chapter 7. Global Macular Degeneration Treatment Market - Distribution Channel Segment Analysis
- 7.1. Global macular degeneration treatment market overview: by distribution channel
- 7.1.1. Global macular degeneration treatment market revenue share, by distribution channel, 2018 and 2025
- 7.2. Ambulatory Surgical Centers
- 7.2.1. Global macular degeneration treatment market by Ambulatory Surgical Centers, 2016-2025 (USD Million)
- 7.3. Ophthalmic Clinics
- 7.3.1. Global macular degeneration treatment market by Ophthalmic Clinics, 2016-2025 (USD Million)
- 7.4. Hospitals
- 7.4.1. Global macular degeneration treatment market by Hospitals, 2016-2025 (USD Million)
- 7.1. Global macular degeneration treatment market overview: by distribution channel
- Chapter 8. Global Macular Degeneration Treatment Market - Regional Analysis
- 8.1. Global macular degeneration treatment market overview: by region
- 8.1.1. Global macular degeneration treatment market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America macular degeneration treatment market, by country, 2016-2025 (USD Million)
- 8.2.2. North America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.2.3. North America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.2.4. North America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.2.5.2. The U.S. macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.2.5.3. The U.S. macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.2.6.2. Rest of North America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.2.6.3. Rest of North America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe macular degeneration treatment market, by country, 2016-2025 (USD Million)
- 8.3.2. Europe macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.3.3. Europe macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.3.4. Europe macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.3.5. U.K.
- 8.3.5.1. U.K. macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.3.5.2. U.K. macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.3.5.3. U.K. macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.3.6.2. France macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.3.6.3. France macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.3.7.2. Germany macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.3.7.3. Germany macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.3.8.2. Rest of Europe macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.3.8.3. Rest of Europe macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific macular degeneration treatment market, by country, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.4.3. Asia Pacific macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.4.4. Asia Pacific macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.4.5. China
- 8.4.5.1. China macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.4.5.2. China macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.4.5.3. China macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.4.6.2. Japan macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.4.6.3. Japan macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.4.7. India
- 8.4.7.1. India macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.4.7.2. India macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.4.7.3. India macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.4.8.2. Rest of Asia Pacific macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.4.8.3. Rest of Asia Pacific macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America macular degeneration treatment market, by country, 2016-2025 (USD Million)
- 8.5.2. Latin America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.5.3. Latin America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.5.4. Latin America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.5.5.2. Brazil macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.5.5.3. Brazil macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.5.6.2. Rest of Latin America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.5.6.3. Rest of Latin America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa macular degeneration treatment market, 2016-2025 (USD Million)
- 8.6.2. Middle East & Africa macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
- 8.6.3. Middle East & Africa macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
- 8.6.4. Middle East & Africa macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
- 8.1. Global macular degeneration treatment market overview: by region
- Chapter 9. Company Profiles
- 9.1. Valeant Pharmaceuticals
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Drug Class Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Pfizer, Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Drug Class Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Santen Pharmaceuticals
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Drug Class Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Sanofi
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Drug Class Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. F. Hoffmann-La Roche
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Drug Class Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. StemCells
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Drug Class Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Neurotech Pharmaceuticals
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Drug Class Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Ophthotech Corporation
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Drug Class Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Bayer AG
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Drug Class Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. GlaxoSmithKline
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Drug Class Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.11. Novartis
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Drug Class Portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Developments
- 9.12. Allergan
- 9.12.1. Overview
- 9.12.2. Financials
- 9.12.3. Drug Class Portfolio
- 9.12.4. Business Strategy
- 9.12.5. Recent Developments
- 9.1. Valeant Pharmaceuticals
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global macular degeneration treatment market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: macular degeneration treatment market
5. Global macular degeneration treatment market attractiveness, by drug class
6. Global macular degeneration treatment market attractiveness, by indication
7. Global macular degeneration treatment market attractiveness, by distribution channel
8. Global macular degeneration treatment market revenue share, by drug class, 2018 and 2025
9. Global macular degeneration treatment market by Anti-vascular Endothelial Growth Factor (VEGFs), 2016-2025 (USD Million)
10. Global macular degeneration treatment market by Other Drugs, 2016-2025 (USD Million)
11. Global macular degeneration treatment market revenue share, by indication, 2018 and 2025
12. Global macular degeneration treatment market by Wet Age-related Macular Degeneration (wAMD), 2016-2025 (USD Million)
13. Global macular degeneration treatment market by Dry Age-related Macular Degeneration (dAMD), 2016-2025 (USD Million)
14. Global macular degeneration treatment market revenue share, by distribution channel, 2018 and 2025
15. Global macular degeneration treatment market by Ambulatory Surgical Centers, 2016-2025 (USD Million)
16. Global macular degeneration treatment market by Ophthalmic Clinics, 2016-2025 (USD Million)
17. Global macular degeneration treatment market by Hospitals, 2016-2025 (USD Million)
18. Global macular degeneration treatment market revenue share, by region, 2018 & 2025
19. North America macular degeneration treatment market, 2016-2025 (USD Million)
20. Europe macular degeneration treatment market, 2016-2025 (USD Million)
21. Asia Pacific macular degeneration treatment market, 2016-2025 (USD Million)
22. Latin America macular degeneration treatment market, 2016-2025 (USD Million)
23. Middle East & Africa macular degeneration treatment market, 2016-2025 (USD Million)
Table Of Tables
List of Tables
1. Global macular degeneration treatment market: snapshot
2. Drivers for macular degeneration treatment market: impact analysis
3. Restraints for macular degeneration treatment market: impact analysis
4. North America macular degeneration treatment market revenue, by country, 2016-2025 (USD Million)
5. North America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
6. North America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
7. North America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
8. The U.S. macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
9. The U.S. macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
10. The U.S. macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
11. Rest of North America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
12. Rest of North America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
13. Rest of North America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
14. Europe macular degeneration treatment market revenue, by country, 2016-2025 (USD Million)
15. Europe macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
16. Europe macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
17. Europe macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
18. U.K. macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
19. U.K. macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
20. U.K. macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
21. France macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
22. France macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
23. France macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
24. Germany macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
25. Germany macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
26. Germany macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
27. Rest of Europe macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
28. Rest of Europe macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
29. Rest of Europe macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
30. Asia Pacific macular degeneration treatment market revenue, by country, 2016-2025 (USD Million)
31. Asia Pacific macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
32. Asia Pacific macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
33. Asia Pacific macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
34. China macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
35. China macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
36. China macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
37. Japan macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
38. Japan macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
39. Japan macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
40. India macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
41. India macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
42. India macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
43. Rest of Asia Pacific macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
44. Rest of Asia Pacific macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
45. Rest of Asia Pacific macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
46. Latin America macular degeneration treatment market revenue, by country, 2016-2025 (USD Million)
47. Latin America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
48. Latin America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
49. Latin America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
50. Brazil macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
51. Brazil macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
52. Brazil macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
53. Rest of Latin America macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
54. Rest of Latin America macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
55. Rest of Latin America macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
56. Middle East & Africa macular degeneration treatment market revenue, by drug class, 2016-2025 (USD Million)
57. Middle East & Africa macular degeneration treatment market revenue, by indication, 2016-2025 (USD Million)
58. Middle East & Africa macular degeneration treatment market revenue, by distribution channel, 2016-2025 (USD Million)
Methodology
FrequentlyAsked Questions
Macular degeneration is one of major eye disorder and a leading cause of vision loss, affecting people more than cataracts and glaucoma together. Currently, macular degeneration cannot be cured i.e. it is an incurable disease.
According to study, the Macular Degeneration Treatment Market size was worth around USD 10.02 billion in 2023 and is predicted to grow to around USD 20.54 billion by 2032.
The CAGR value of Macular Degeneration Treatment Market is expected to be around 8.3% during 2024-2032.
North America has been leading the Macular Degeneration Treatment Market and is anticipated to continue on the dominant position in the years to come.
The Macular Degeneration Treatment Market is led by players like Valeant Pharmaceuticals, Santen Pharmaceuticals, Pfizer, Inc., Sanofi, F. Hoffmann-La Roche, StemCells, Neurotech Pharmaceuticals, Ophthotech Corporation, Bayer AG, GlaxoSmithKline, Allergan and Novartis among others.
HappyClients
